AMS IS THE INDUSTRY LEADER IN STRATEGIC INTELLIGENCE SOFTWARE FOR COMBATTING EMERGING HIGH-COST CLAIM ISSUES
What We Do:
AMS delivers crucial insight into catastrophic diagnoses, specialty pharmaceutical, and implant price transparency through clinically vetted, predictive financial analytics with near real-time data.
Who We Serve:
AMS serves multiple stakeholders in the medical claims payment chain, including commercial and governmental payers, Stop Loss and Reinsurance Carriers, MGUs, Medical Management Firms, Health Plans, TPAs, HMOs, Taft-Hartley Plans, workers compensation, and auto medical carriers.
WHO IS USING THE PREDICT SUITE
THE PREDICT SUITE
AMS’ Web-based directories that allow
clients to predict, evaluate and manage high dollar healthcare claims.
PREDICT
Predict costs and clinical treatments for high dollar diagnoses with an on demand decision support solution delivering in-depth clinical information, empirical insight and key financial analytics.
EVALUATE
Evaluate cost data, FDA approved indications, notable off-label usage, adult/pediatric dosing regimens, manufacturer rebates, specialty drug coding and price trends.
MANAGE
Manage highly inflated implant claims by leveraging detailed clinical and financial metrics with the only online, fully- transparent implant cost directory in the industry.
PREDICT SUITE MEMBERSHIP HAS ITS BENEFITS
100%
Reference Rate
Predict Suite Members willing + eager to connect with prospects
99%
Members
Retained
We have retained 99% of our members
13,000
Clinical/Financial Iterations
Including rules, off label + orphan drug uses, price benchmarks and CPT codes
100s
Weekly Hours
Saved
We have saved our clients and members 100s of weekly hours in research and underwriting
AMS Blog
-
Three-drug combination improves life for cystic fibrosis patients
October 19, 2018
“Within 24 hours of taking the pill combination, patients were puffing less, their sinuses were clearer, they had more energy,” one researcher said. All newborns in the U.S. are tested for the genes that cause cystic fibrosis. There is no cure, but new medications may improve symptoms.BSIP / UIG via Getty Images A three-drug cocktail… Read More » -
Local pharmacist changes state law to put high-dollar chemo drugs in the hands of low-income Tennesseans
October 18, 2018
Phil Baker is the founder and CEO of Memphis-based Good Shepherd Pharmacy. (Houston Cofield/Daily Memphian file) After three years, the last domino finally fell. Phil Baker, founder of Good Shepherd Pharmacy, took a call from The Daily Memphian while standing at the foot of the Washington Monument. “Wow,” he said. “I didn’t realize how much… Read More »